ResearchSafe

ALD-52 (1-Acetyl-LSD)

Category: Psychedelics. Status: Schedule I (research compound).

An LSD relative (also called 1A-LSD) thought to convert into LSD in the body. Reported to be slightly gentler and more "clear" than LSD by some users.

How it works

Likely a prodrug for LSD acting on serotonin 5-HT2A receptors.

Key facts

  • Molecular weight: 349.43 g/mol
  • Half-life: ~3-5 hours
  • Bioavailability: Oral
  • Storage: Research/reference only.

Dosing overview

  • Typical dose: Varies by individual and setting
  • Frequency: Occasional
  • Duration: Acute effects last 8-12 hours
  • Route: Oral

Protocol notes

  • Taken orally on blotter, used just like LSD with a similar long duration.

Reported benefits

  • LSD-like experience
  • Reported slightly gentler
  • Lysergamide research compound
  • Long duration

Possible side effects

  • Long, intense experiences
  • Anxiety
  • Raised heart rate and blood pressure
  • Limited human data

Compare ALD-52

Research and educational reference only. Not medical advice.